You have 9 free searches left this month | for more free features.

Condition

Cancer of Unknown Primary Site (1)

Hepatocellular Carcinoma (1)

Microsatellite Instability (1)

Mismatch Repair Deficiency (1)

Renal Cell Carcinoma (1)

Solid Tumor (1)

Overall Status

Completed (1)

Terminated (1)

Sign in for free

Phase

phase 1 (1)

phase 1/phase 2 (1)

Sponsor

Apollomics (Australia) Pty. Ltd. (2)

Collaborator

Apollomics Inc. (formerly CBT Pharmaceuticals, Inc.) (2)

Novotech (Australia) Pty Limited (2)

Intervention

apl-501 (2)

apl-101 (1)

nivolumab (1)

Study Documents

Intervention Type

drug (2)

biological (1)

Funder Type

Industry (2)

Study Type

Interventional (2)

apl-501

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Hepatocellular Carcinoma, Renal Cell Carcinoma Trial in Australia, New Zealand (APL-501, APL-101, Nivolumab)

Terminated

Hepatocellular Carcinoma
Renal Cell Carcinoma

APL-501
+2 more

Albury, New South Wales, Australia
+8 more

May 3, 2022

Solid Tumor, Microsatellite Instability, Mismatch Repair Deficiency Trial in Australia (APL-501)

Completed

Solid Tumor
+3 more

APL-501

Camperdown, New South Wales, Australia
+4 more

May 5, 2022